.jpg "DENTSPLY SIRONA Inc (NASDAQ: XRAY)")
In a report issued on January 4, Steven Valiquette from Barclays maintained a Hold rating on DENTSPLY SIRONA Inc (XRAY), with a price target of $39. The company’s shares closed on Friday at $39.01, close to its 52-week low of $33.93.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 4.1% and a 48.2% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Patterson Companies Inc, and WellCare Health Plans.
Currently, the analyst consensus on DENTSPLY SIRONA Inc is a Moderate Buy with an average price target of $41.17.
See today’s analyst top recommended stocks >>
Based on DENTSPLY SIRONA Inc’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $28 million. In comparison, last year the company earned revenue of $1.09 billion and had a GAAP net loss of $673 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment and Consumables segments.
